KAWAIN (10711)

Compound Details

NameKAWAIN
Compound class340013570
Compound codeMISC LACTONE

Summary

Compound class: 340013570

Experiments: 96

View Experiments

Experiments (96)

Filters
Worktypes (32)
19
19
17
15
14
12
10
8
6
5
4
4
3
3
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
No match
Pharmacology (30)
5
4
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
52
No match
Compounds (25)
96
36
35
33
29
24
10
3
3
3
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
No match
Organisms (75)
4
4
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
96 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)
66882
PHARMACOLOGY OF COMPOUND - IN HUMANS
CNS EFFECTS(GENERAL)
Empty organism
64639
PHARMACOLOGY OF COMPOUND - IN VIVO
SKELETAL MUSCLE RELAXANT EFFECT(CENTRAL)
Empty organism
66774
PHARMACOLOGY OF COMPOUND - IN HUMANS
ANXIOLYTIC EFFECT
Empty organism
1128452
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Piper methysticum (PIPERACEAE)
696980
MICROBIAL TRANSFORMATION OF
Cunninghamella elegans (CUNNINGHAMELLACEAE)
65243
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTICONVULSANT ACTIVITY
Empty organism
1270071
MARKER CODE - FERTILITY REGULATION. NO RETRIEVABLE DATAPHARMACOLOGY OF COMPOUND - IN VITRO
SEROTONIN (5-HT) ANTAGONIST ACTIVITY
Empty organism
678234
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIOXIDANT ACTIVITY
Empty organism
369864
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Piper methysticum (PIPERACEAE)
1248232
IDENTIFICATION IN BY GLC
Piper methysticum (PIPERACEAE)
1066682
COMPLETE SYNTHESIS REPORTED
Piper methysticum (PIPERACEAE)
53705
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTICONVULSANT ACTIVITY
Piper methysticum (PIPERACEAE)
1255659
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Piper methysticum (PIPERACEAE)
1100465
IDENTIFICATION IN BY GLC
Piper methysticum (PIPERACEAE)
703129
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDPCR ANALYSIS(PLANT)
Piper methysticum (PIPERACEAE)
792336
IDENTIFICATION IN BY TLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED
Piper methysticum (PIPERACEAE)
66782
PHARMACOLOGY OF COMPOUND - IN HUMANS
ANXIOLYTIC EFFECT
Empty organism
523612
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIISCHEMIC EFFECT
Empty organism
735435
IDENTIFICATION IN BY TLC
Piper methysticum (PIPERACEAE)
64630
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTICONVULSANT ACTIVITY
Piper methysticum (PIPERACEAE)
749523
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Piper methysticum (PIPERACEAE)
1100461
IDENTIFICATION IN BY GLC
Piper methysticum (PIPERACEAE)
1076829
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Piper methysticum (PIPERACEAE)
749520
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Piper methysticum (PIPERACEAE)
66883
PHARMACOLOGY OF COMPOUND - IN HUMANS
ANXIOLYTIC EFFECT
Empty organism
855439
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Piper methysticum (PIPERACEAE)
751785
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Piper methysticum (PIPERACEAE)
64638
PHARMACOLOGY OF COMPOUND - IN VIVO
CNS DEPRESSANT ACTIVITY
Empty organism
346714
PHARMACOLOGY OF COMPOUND - IN VITRO
SODIUM CHANNEL BLOCKING EFFECT
Empty organism
642821
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTICATALEPTIC ACTIVITY
Empty organism
1158569
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIAMEBIC ACTIVITY
Empty organism
380614
PHARMACOLOGY OF COMPOUND - IN HUMANS
ANXIOLYTIC EFFECT
Empty organism
1100462
IDENTIFICATION IN BY GLC
Piper methysticum (PIPERACEAE)
65242
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTICONVULSANT ACTIVITY
Empty organism
53706
PHARMACOLOGY OF COMPOUND - IN VIVO
CNS DEPRESSANT ACTIVITY
Piper methysticum (PIPERACEAE)
764637
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Piper methysticum (PIPERACEAE)
855438
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Piper methysticum (PIPERACEAE)
386258
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTEDIDENTIFICATION IN BY GC/MS
Piper methysticum (PIPERACEAE)
747178
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCPATENT DESCRIBEDHPLC SEPARATION DATA FOR
Piper methysticum (PIPERACEAE)
382555
PHARMACOLOGY OF COMPOUND - IN VIVO
PHARMACOKINETIC STUDY OF
Empty organism
654601
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIINFLAMMATORY ACTIVITY
Empty organism
348067
PHARMACOLOGY OF COMPOUND - IN VITRO
ELECTROPHYSIOLOGICAL EFFECTS
Empty organism
788110
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Piper methysticum (PIPERACEAE)
634694
PHARMACOLOGY OF COMPOUND - IN VITRO
SEROTONIN (5-HT) ANTAGONIST ACTIVITY
Empty organism
393238
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Piper methysticum (PIPERACEAE)
778025
PHARMACOLOGY OF COMPOUND - IN VITRO
VASOCONSTRICTION INHIBITION ACTIVITY
Empty organism
67449
PHARMACOLOGY OF COMPOUND - IN HUMANS
HEPATOTOXIC ACTIVITY
Empty organism
280457
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Piper methysticum (PIPERACEAE)
764245
IDENTIFICATION IN BY TLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Piper methysticum (PIPERACEAE)
1128450
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Piper methysticum (PIPERACEAE)
1064108
PHARMACOLOGY OF COMPOUND - IN VIVO
METABOLISM OF
Piper methysticum (PIPERACEAE)
769722
IDENTIFICATION IN BY GLCGC DATA REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Piper methysticum (PIPERACEAE)
739056
GC DATA REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Piper methysticum (PIPERACEAE)
65241
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTICONVULSANT ACTIVITY
Empty organism
802932
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Piper methysticum (PIPERACEAE)
751786
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Piper methysticum (PIPERACEAE)
1100463
IDENTIFICATION IN BY GLC
Piper methysticum (PIPERACEAE)
749522
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 2 INHIBITION
Piper methysticum (PIPERACEAE)
63872
PHARMACOLOGY OF COMPOUND - IN VIVO
SKELETAL MUSCLE RELAXANT EFFECT(CENTRAL)
Empty organism
53704
UV SPECTRUM GIVEN FORQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Piper methysticum (PIPERACEAE)
1160770
ISOLATION AND IDENTIFICATION OF
Piper methysticum (PIPERACEAE)
1100466
IDENTIFICATION IN BY GLC
Piper methysticum (PIPERACEAE)
382554
ISOLATION AND IDENTIFICATION OF
Empty organism
53707
PHARMACOLOGY OF COMPOUND - IN VIVO
BARBITURATE POTENTIATION
Piper methysticum (PIPERACEAE)
251941
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Acremonium neo-caledoniae (HYPHOMYCETES)
64629
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Piper methysticum (PIPERACEAE)
523611
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIISCHEMIC EFFECT
Empty organism
1269626
UV SPECTRUM GIVEN FORWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESISOLATION AND IDENTIFICATION OF
Piper methysticum (PIPERACEAE)
393891
PMR SPECTRUM REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATAHPLC SEPARATION DATA FOR
Piper methysticum (PIPERACEAE)
52919
UV SPECTRUM GIVEN FORWORK DESCRIBED MAINLY CONCERNS METHODOLOGYTLC PATTERN REPORTED FORQUANTITATIVE DATA REPORTEDSPECTROPHOTOMETRIC ASSAY OFISOLATION AND IDENTIFICATION OF
Piper methysticum (PIPERACEAE)
821300
COMPLETE SYNTHESIS REPORTED
Empty organism
947214
ISOLATION AND IDENTIFICATION OF
Piper methysticum (PIPERACEAE)
1064107
PHARMACOLOGY OF COMPOUND - IN VIVO
METABOLISM OF
Piper methysticum (PIPERACEAE)
783518
IDENTIFICATION IN BY GLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Piper methysticum (PIPERACEAE)
1270070
PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY
UTERINE RELAXATION EFFECT
Empty organism
1247130
QUANTITATIVE DATAYIELD IS LESS THAN 50 MGMISOLATION AND IDENTIFICATION OF
Piper methysticum (PIPERACEAE)
805675
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION OF A KNOWN COMPOUND USING SUPERCRITICAL FLUID
Piper methysticum (PIPERACEAE)
1128451
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Piper methysticum (PIPERACEAE)
1100464
IDENTIFICATION IN BY GLC
Piper methysticum (PIPERACEAE)
1272984
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Piper methysticum (PIPERACEAE)
63873
PHARMACOLOGY OF COMPOUND - IN VIVO
MISCELLANEOUS EFFECTS
Empty organism
602132
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Piper methysticum (PIPERACEAE)
1299488
IDENTIFICATION IN BY HPLC
Piper methysticum (PIPERACEAE)
788111
PHARMACOLOGY OF COMPOUND - IN VIVO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Piper methysticum (PIPERACEAE)
634073
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Piper methysticum (PIPERACEAE)
428227
PHARMACOLOGY OF COMPOUND - IN VITRO
BENZODIAZEPINE BINDING INHIBITION
Empty organism
64628
ISOLATION AND IDENTIFICATION OF
Piper methysticum (PIPERACEAE)
392312
PHARMACOLOGY OF COMPOUND - IN VITRO
SODIUM CHANNEL BLOCKING EFFECT
Empty organism
805872
GC DATA REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTED
Empty organism
749521
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 1 INHIBITION
Piper methysticum (PIPERACEAE)
1097040
IDENTIFICATION IN BY GLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED
Piper methysticum (PIPERACEAE)
320060
PARTIAL SYNTHESIS OF
Empty organism
695087
PHARMACOLOGY OF COMPOUND - IN VITRO
SMOOTH MUSCLE RELAXANT ACTIVITY
Empty organism
1160771
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Piper methysticum (PIPERACEAE)
947215
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Piper methysticum (PIPERACEAE)
601337
ISOLATION AND IDENTIFICATION OF
Piper methysticum (PIPERACEAE)
Show SPARQL Queries (1)